IP Library Granted Patent US 7,968,287
Granted Patent B2
US 7,968,287 · App. 10/961,695 · Granted Jun 28, 2011

In vitro evolution in microfluidic systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,968,287
App. No.
10/961,695
Granted
Jun 28, 2011
Kind
B2
Abstract

The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; and (b) sorting the genetic elements which express the gene product having the desired activity; wherein at least one step is under microfluidic control. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.

Claims (9)

1. A method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of:

providing one or more genetic elements;

compartmentalising the genetic elements into a microcapsule by forming a water-in-fluorocarbon or water-in-perfluorocarbon emulsion microcapsule within a microfluidic device;

expressing the genetic elements to produce their respective gene products within the microcapsules; and

sorting the genetic elements which express gene product(s) having the desired activity; wherein the method is under microfluidic control.

2. A method according to claim 1 , wherein the fluorocarbon is perfluorooctyl bromide or perfluorooctylethane.

3. A method according to claim 1 , wherein the emulsion is formed using F-alkyl dimorpholinophosphate(s).

4. A method according to claim 3 , wherein the F-alkyl dimorpholinophosphate(s) have the general formula C n F 2 +1C m H 2 mOP(O)[N(CH 2 CH 2 ) 2 O] 2 .

5. A method according to claim 4 wherein the F-alkyl dimorpholinophosphate is C 8 F 17 C 11 H 22 OP(O)[N(CH 2 CH 2 ) 2 O] 2 .

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: MEDICAL RESEARCH COUNCIL
To: UNITED KINGDOM RESEARCH AND INNOVATION
Reel/Frame 046469/0108 →
CONFIRMATORY LICENSE Recorded Jul 22, 2015
From: HARVARD UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 036150/0696 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2005
From: WEITZ, DAVID; LINK, DARREN R.; AHN, KCUNHO; BIBETLE, JEROME
To: PRESIDENT AND FELLOWS HARVARD COLLEGE
Reel/Frame 017081/0428 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2005
From: GRIFFITHS, ANDREW
To: MEDICAL RESEARCH COUNCIL
Reel/Frame 016706/0982 →